Little Green Pharma Ltd (ASX: LGP) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Little Green Pharma Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $39.37 million
P/E Ratio 1.61
Dividend Yield 0.00%
Shares Outstanding 301.76 million
Earnings per share -0.027
Dividend per share N/A
Year To Date Return -40.00%
Earnings Yield 62.11%
Franking -
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • Little Green Pharma Ltd (ASX: LGP)
    Latest News

    asx cannabis shares represented by pug dog pointing to blackboard with cannabis info on it
    Share Market News

    Why the Little Green Pharma (ASX:LGP) share price climbed 5% today

    The Little Green Pharma (ASX: LGP) share price climbed higher today after the company announced it has delivered its first…

    Read more »

    A businessman holds his glasses in concern, indicating uncertainly in the ASX share price
    Share Market News

    The Little Green Pharma (ASX:LGP) share price dived 16% after this announcement

    The Little Green Pharma share price has taken a dive today after the company announced a $22 million share placement.…

    Read more »

    A man with binoculars crouched in the bush, indication a share price on watch
    Share Market News

    Why the Little Green Pharma (ASX:LGP) share price will be on watch today

    The Little Green Pharma Ltd (ASX: LGP) share price will be on watch today after announcing progress on it first…

    Read more »

    cannabis leaves on a rising line graph representing growth of ASX cannabis share price
    Share Market News

    Little Green Pharma (ASX:LGP) share price whiskers near all-time high

    The Little Green Pharma Ltd (ASX: LGP) share price is closing in on a record high on news of a…

    Read more »

    US flag and senate building with blue sky in background
    Share Market News

    What does the Biden administration mean for ASX shares? 

    With Joe Biden due to take office this week, many investors are wondering what this could mean for ASX shares.…

    Read more »

    little green pharma share price represented by cannabis leaf character jumping cheerfully
    Share Market News

    Little Green Pharma (ASX:LGP) share price leaps 10% on this ASX announcement

    Here's why the Little Green Pharma share price is up 10% in late afternoon trading. We take a closer look…

    Read more »

    LGP ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Little Green Pharma Ltd

    Little Green Pharma Ltd is engaged in the vertically integrated medicinal cannabis business. The business activities of the company include cultivation, production, research and development, manufacturing, and distribution of medicinal cannabis products. The company's two key types of products available at Little Green Pharma are oils (which are ingested) and flowers (which are usually inhaled through vaporizing). It offers LGP-branded medicinal cannabis oil products in the Australian and European markets.

    LGP Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    21 Nov 2024 $0.13 $0.00 0.00% 246,945 $0.14 $0.14 $0.13
    20 Nov 2024 $0.13 $-0.01 -7.41% 165,399 $0.13 $0.14 $0.13
    19 Nov 2024 $0.14 $0.01 7.69% 130,042 $0.13 $0.14 $0.13
    18 Nov 2024 $0.13 $0.01 8.00% 210,555 $0.13 $0.13 $0.12
    15 Nov 2024 $0.13 $-0.01 -7.69% 5,834 $0.12 $0.14 $0.12
    14 Nov 2024 $0.13 $0.00 0.00% 604,227 $0.13 $0.14 $0.13
    13 Nov 2024 $0.13 $0.02 17.39% 307,632 $0.12 $0.13 $0.12
    12 Nov 2024 $0.12 $0.00 0.00% 438,456 $0.13 $0.13 $0.12
    11 Nov 2024 $0.12 $0.00 0.00% 88,718 $0.12 $0.12 $0.12
    08 Nov 2024 $0.12 $0.00 0.00% 274,002 $0.12 $0.12 $0.12
    07 Nov 2024 $0.12 $0.00 0.00% 20,692 $0.12 $0.12 $0.12
    06 Nov 2024 $0.12 $-0.01 -8.00% 427,334 $0.13 $0.13 $0.12
    05 Nov 2024 $0.13 $0.00 0.00% 48,014 $0.13 $0.13 $0.12
    04 Nov 2024 $0.13 $0.01 8.33% 579,913 $0.12 $0.13 $0.12
    01 Nov 2024 $0.12 $-0.02 -14.81% 564,836 $0.15 $0.15 $0.12
    31 Oct 2024 $0.14 $0.00 0.00% 144,853 $0.14 $0.14 $0.13
    30 Oct 2024 $0.14 $-0.01 -7.14% 191,799 $0.14 $0.15 $0.14
    29 Oct 2024 $0.14 $0.00 0.00% 553,676 $0.14 $0.16 $0.14
    28 Oct 2024 $0.14 $0.00 0.00% 326,193 $0.15 $0.16 $0.14
    25 Oct 2024 $0.15 $-0.01 -6.45% 1,391,231 $0.16 $0.16 $0.15
    24 Oct 2024 $0.16 $0.01 6.90% 345,217 $0.15 $0.16 $0.15
    23 Oct 2024 $0.15 $-0.01 -6.45% 25,059,808 $0.16 $0.16 $0.15

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    02 Sep 2024 Angus Caithness Issued 2,000,000 $184,000
    Issue of options. As per announcement on 06-09-2024
    02 Sep 2024 Fleta Solomon Issued 1,200,000 $110,400
    Issue of options. As per announcement on 06-09-2024
    15 Apr 2024 Fleta Solomon Exercise 36,000 $5,040
    Conversion of securities. 4,000,000 Rights
    15 Apr 2024 Fleta Solomon Issued 36,000 $5,040
    Conversion of securities.
    15 Apr 2024 Angus Caithness Issued 32,000 $4,480
    Conversion of securities. Typo error
    15 Apr 2024 Angus Caithness Exercise 32,000 $4,480
    Conversion of securities. 4,000,000 Rights, Typo error
    03 Apr 2024 Neale Fong Exercise 35,000 $5,250
    Conversion of securities. 105,000 Retention Share Rights
    03 Apr 2024 Neale Fong Buy 35,000 $5,250
    Conversion of securities.
    03 Apr 2024 Michael Lynch-Bell Buy 70,000 $10,500
    Conversion of securities.
    03 Apr 2024 Michael Lynch-Bell Exercise 70,000 $10,500
    Conversion of securities. 210,000 Retention Share Rights

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Dr Neale William Fong Non-Executive Director Nov 2018
    Dr Fong has over 36 years in leadership roles in private hospitals, the public health systems, management consulting, academia, health research, aged care and not for profit organisations. Neale is currently CEO of Bethesda Health Care and formerly was Director General of the West Australian Department of Health. Neale is also Chair of the Risk Committee.
    Mr Angus McDougall Caithness Executive Director Feb 2018
    Mr Caithness is a corporate finance executive and consultant in Australia and international markets. Angus has ASX experience as a Company Secretary for the IPO of Haranga Resources (ASX:HAR). Following these roles, Angus acted as CFO of Tavan Tolgoi, the owner of coking coal deposit looking at a US$10 billion dual listing in London and Hong Kong prior to the change in the Mongolian government. Angus was previously an Executive Director at Ernst & Young in London and Australia specialising in initial public offerings of large cap mining companies.
    Ms Fleta Jennifer Solomon Chief Executive OfficerManaging Director May 2017
    Ms Solomon was a founder of Little Green Pharma and has grown the company from a medicinal cannabis startup to an industry leading medicinal cannabis brand in Australia and overseas. Fleta has 20 years' experience in corporate and consumer health markets.
    Mr Michael David Lynch-Bell Non-Executive ChairmanNon-Executive Director Nov 2018
    Mr Lynch-Bell is a corporate finance executive and consultant. His early Ernst & Young career was focused on auditing clients within the oil and gas sectors and later added mining to his portfolio. Michael also led Ernst & Young's UK IPO and Global Natural Resources transaction teams in the Transaction Advisory practice. He has been involved advising companies on fundraising, re organisations, transactions, corporate governance as well as IPOs. Michael is a former Chair of the Bureau and current member of UNECE's Expert Group on Resource Management, non-executive Chair of Serabi Gold plc (SRB.L), and Senior Independent Director and Remuneration Committee Chair of Gem Diamonds Limited (LSE:GEMD).
    Ms Beatriz Vicen Banzo Non-Executive Director Jul 2022
    Ms Banzo has over 30 years working in the European pharmaceutical industry and is experienced and decorated expert in European pharmaceutical regulatory and quality assurance matters. Prior to joining LGP, Beatriz was the Director of Public Affairs (Market Access and Patient Advocacy), Regulatory and Quality Assurance for Bayer Pharmaceuticals and Consumer Health in Spain, Head of Regulatory Affairs and Permanent Executive Committee Guest at Novartis Pharmaceutical Company. Since 2015, Beatriz has also lectured the Masters program at the Madrid based Professional College Talento Farmaceutico and is fluent in four languages.
    Mr Alistair Warren Company Secretary Jul 2020
    -
    Paul Long Chief Executive Officer
    -
    Alistair Warren Company Secretary
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    HSBC Custody Nominees (Australia) Limited 32,309,383 10.71%
    Ubs Nominees Pty Ltd 32,256,846 10.69%
    Ms Fleta Jennifer Solomon 21,873,216 7.25%
    Barbright Australia Pty Ltd <Interquartz Super A/C> 14,420,420 4.78%
    Bnp Paribas Nominees Pty Ltd Acf Clearstream 7,334,936 2.43%
    Mr Angus Caithness 5,751,441 1.91%
    Banquo Consulting Pty Ltd 5,413,333 1.79%
    Finclear Services Pty Ltd <Superhero Securities A/C> 4,217,543 1.40%
    Cg Nominees (Australia) Pty Ltd 4,147,061 1.37%
    Benoni Pty Ltd <The Mkj Super Fund A/C> 4,082,127 1.35%
    Citicorp Nominees Pty Limited 2,906,193 0.96%
    Mr Paul Frederick Long <The Long A/C> 2,426,191 0.80%
    Ms Jenny Lorraine Mckay <J and K Mckay Family A/C> 2,229,746 0.74%
    Mr Damien Matthew Booth <Damien Booth Family A/C> 1,858,639 0.62%
    Mr Michael David Lynch Bell 1,758,450 0.58%
    Jasforce Pty Ltd 1,705,556 0.57%
    BNP Paribas Nominees Pty Ltd <Ib Au Noms Retailclient> 1,557,072 0.52%
    Mr Sean Edward Reid and Ms Louise Jane Pilkington 1,552,600 0.51%
    Jensen Jarrah Pty Ltd 1,369,231 0.45%
    Ms Rhianna Louise Belcham 1,250,000 0.41%

    Profile

    since

    Note